Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
BIOTIME, INC.
     
Date: August 9, 2017
/s/ Michael D. West
 
 
Michael D. West, Ph.D.
 
Co-Chief Executive Officer

Date: August 9, 2017
/s/ Aditya Mohanty
 
 
Aditya Mohanty
 
Co-Chief Executive Officer
 
Date: August 9, 2017
/s/ Russell L. Skibsted
 
 
Russell L. Skibsted
 
Chief Financial Officer

 
29

© Copyright BioTime, Inc.